Literature DB >> 33038275

Weight change in middle adulthood and risk of cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Sofia Christakoudi1,2, Panagiota Pagoni3,4,5, Pietro Ferrari6, Amanda J Cross1, Ioanna Tzoulaki1,3, David C Muller1, Elisabete Weiderpass6, Heinz Freisling6, Neil Murphy6, Laure Dossus6, Renee Turzanski Fortner7, Antonio Agudo8, Kim Overvad9,10, Aurora Perez-Cornago11, Timothy J Key11, Paul Brennan6, Mattias Johansson6, Anne Tjønneland12, Jytte Halkjaer12, Marie-Christine Boutron-Ruault13, Fanny Artaud13, Gianluca Severi13,14, Rudolf Kaaks7, Matthias B Schulze15,16, Manuela M Bergmann17, Giovanna Masala18, Sara Grioni19, Vittorio Simeon20, Rosario Tumino21, Carlotta Sacerdote22, Guri Skeie23, Charlotta Rylander23, Kristin Benjaminsen Borch23, J Ramón Quirós24, Miguel Rodriguez-Barranco25,26,27, Maria-Dolores Chirlaque27,28,29, Eva Ardanaz27,30,31, Pilar Amiano27,32, Isabel Drake33, Tanja Stocks34, Christel Häggström35,36, Sophia Harlid37, Merete Ellingjord-Dale1, Elio Riboli1, Konstantinos K Tsilidis1,3.   

Abstract

Obesity is a risk factor for several major cancers. Associations of weight change in middle adulthood with cancer risk, however, are less clear. We examined the association of change in weight and body mass index (BMI) category during middle adulthood with 42 cancers, using multivariable Cox proportional hazards models in the European Prospective Investigation into Cancer and Nutrition cohort. Of 241 323 participants (31% men), 20% lost and 32% gained weight (>0.4 to 5.0 kg/year) during 6.9 years (average). During 8.0 years of follow-up after the second weight assessment, 20 960 incident cancers were ascertained. Independent of baseline BMI, weight gain (per one kg/year increment) was positively associated with cancer of the corpus uteri (hazard ratio [HR] = 1.14; 95% confidence interval: 1.05-1.23). Compared to stable weight (±0.4 kg/year), weight gain (>0.4 to 5.0 kg/year) was positively associated with cancers of the gallbladder and bile ducts (HR = 1.41; 1.01-1.96), postmenopausal breast (HR = 1.08; 1.00-1.16) and thyroid (HR = 1.40; 1.04-1.90). Compared to maintaining normal weight, maintaining overweight or obese BMI (World Health Organisation categories) was positively associated with most obesity-related cancers. Compared to maintaining the baseline BMI category, weight gain to a higher BMI category was positively associated with cancers of the postmenopausal breast (HR = 1.19; 1.06-1.33), ovary (HR = 1.40; 1.04-1.91), corpus uteri (HR = 1.42; 1.06-1.91), kidney (HR = 1.80; 1.20-2.68) and pancreas in men (HR = 1.81; 1.11-2.95). Losing weight to a lower BMI category, however, was inversely associated with cancers of the corpus uteri (HR = 0.40; 0.23-0.69) and colon (HR = 0.69; 0.52-0.92). Our findings support avoiding weight gain and encouraging weight loss in middle adulthood.
© 2020 The Authors. International Journal of Cancer published by John Wiley & Sons Ltd on behalf of Union for International Cancer Control.

Entities:  

Keywords:  BMI change; cancer; middle adulthood; weight gain; weight loss

Mesh:

Year:  2020        PMID: 33038275     DOI: 10.1002/ijc.33339

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

Review 1.  The timing of adiposity and changes in the life course on the risk of cancer.

Authors:  Zhe Fang; Edward L Giovannucci
Journal:  Cancer Metastasis Rev       Date:  2022-07-30       Impact factor: 9.237

Review 2.  Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery.

Authors:  Shuhei Shinoda; Naohiko Nakamura; Brett Roach; David A Bernlohr; Sayeed Ikramuddin; Masato Yamamoto
Journal:  Biomedicines       Date:  2022-05-31

3.  Association of body-shape phenotypes with imaging measures of body composition in the UK Biobank cohort: relevance to colon cancer risk.

Authors:  Sofia Christakoudi; Konstantinos K Tsilidis; Evangelos Evangelou; Elio Riboli
Journal:  BMC Cancer       Date:  2021-10-15       Impact factor: 4.430

Review 4.  The association of obesity with thyroid carcinoma risk.

Authors:  Xiao-Ni Ma; Cheng-Xu Ma; Li-Jie Hou; Song-Bo Fu
Journal:  Cancer Med       Date:  2022-01-15       Impact factor: 4.452

Review 5.  Modifiable and Non-Modifiable Risk Factors for the Development of Non-Hereditary Pancreatic Cancer.

Authors:  Marek Olakowski; Łukasz Bułdak
Journal:  Medicina (Kaunas)       Date:  2022-07-22       Impact factor: 2.948

6.  A Body Shape Index (ABSI), hip index, and risk of cancer in the UK Biobank cohort.

Authors:  Sofia Christakoudi; Konstantinos K Tsilidis; Evangelos Evangelou; Elio Riboli
Journal:  Cancer Med       Date:  2021-07-01       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.